Research Services
The Research Services Division of Myrexis, Inc. provides contract services associated with a wide variety of drug discovery techniques employed throughout the pre-clinical development process. We begin with target identification using our ProNet® industrial throughput Yeast Two-Hybrid (Y2H) platform to elucidate novel target proteins for specific disease areas. Next, our highly skilled biochemists and cellular biologists can develop assays which are then used to validate the target protein within the disease framework. Finally, additional development can be undertaken to render an assay for high throughput screening using our compound libraries or those provided. Our experience in drug discovery & development makes Myrexis Research Services the choice for outsourcing both your discovery and development needs.
